A. Olschewski (Graz, Austria), N. Weissmann (Giessen, Germany)
LSC 2014 abstract - Combined effects of inflammatory mediators and BMPR2 mutation on pulmonary arterial cell function in a pulmonary arterial hypertension
L. Vengethasamy, R. Quarck, M. Delcroix (Leuven, Belgium)
|  |
Mutational and epigenetic analysis of the promoter region of BMPR2 gene in patients with pulmonary arterial hypertension
G. Pousada, A. Baloira, D. Valverde (Vigo, Pontevedra, Spain)
| |
Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension
D. Shao, F. Perros, C. Meng, G. Caramori, M. Humbert, P. C. Chou, I. Adcock, S. Wort (London, United Kingdom; Paris, France; Ferrara, Italy)
| |
miR-126; link between angiogenesis and exercise intolerance in pulmonary arterial hypertension
F. Potus, S. Malenfant, S. Breuils-Bonnet, S. Bonnet, S. Provencher (Quebec, Canada)
| |
Lung heparan and chondroitine sulfate imbalance and functional changes in pulmonary hypertension
B. Ranchoux, E. Henault, S. J. Dumas, S. Chantepie, D. Montani, B. Girerd, A. Blanchet de la Sablière, E. Fadel, P. Dartevelle, D. Papy-Garcia, M. Humbert, F. Perros, P. Albanese, S. Cohen-Kaminsky (Le Plessis Robinson, Le Kremlin Bicêtre, Créteil, France)
| |
Role of class IIa histone deacetylases in the pathogenesis of pulmonary hypertension
E. Gamen, F. Grimminger, W. Seeger, S. Savai Pullamsetti (Bad Nauheim, Giessen, Germany)
| |
Inhibition of the miRNA familiy miR-130 restores the expression of CDKN1A (p21) and ameliorates hypoxia-induced pulmonary hypertension
M. Brock, T. J. Haider, M. Gassmann, J. Vogel, M. Kohler, S. Ulrich, L. C. Huber (Zurich, Switzerland)
|  |
Inflammasome ASC-knock out attenuates the development of pulmonary hypertension caused by chronic alveolar hypoxia
F. T. Cero, K. O. Larsen, V. Hillestad, I. Sjaastad, A. Yndestad, P. Aukrust, E. Lien, E. M. Løberg, G. Christensen, O. H. Skjønsberg (Oslo, Norway; Worcester, United States Of America)
| |
PKCalpha deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A2 via increased TXA2 receptor expression
C. Tabeling, E. Noe, J. Naujoks, J. M. Doehn, S. Hippenstiel, B. Opitz, N. Suttorp, R. Klopfleisch, M. Witzenrath (Berlin, Germany)
| |
Obligatory role of MEK/ERK/RSK90 in the mitogenic responses of human pulmonary artery smooth muscle cells
I. Blanco, T. K. Kolb, L. Johnston, P. M. Hassoun, R. L. Damico (Barcelona, Spain; Baltimore, United States Of America)
| |
Endothelial microparticles and progenitor cells in pulmonary arterial hypertension
J. García-Lucio, N. Chamorro, R. del Pozo, O. Tura-Ceide, N. Coll, C. Bonjoch, I. Crespo, V. I. Peinado, J. A. Barberà (Barcelona, Spain)
| |
M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines
L. Harbaum, J. Wellbrock, J. Diedrich, J. K. Hennigs, J. Heyckendorf, C. Bokemeyer, W. Fiedler, H. Klose, N. Lüneburg (Hamburg, Germany)
| |
Th17 inflammation and pulmonary hypertension
A. Hautefort, B. Girerd, D. Montani, M. Humbert, F. Perros (Le Kremlin-Bicêtre, Le Plessis-Robinson, France)
| |
Acid sphingomyelinase, a novel pathway for pulmonary vasoconstriction. Activation by apoptotic T cell microparticles and Fas ligand
J. Javier Moral-Sanz, D. Morales-Cano, B. Barreira, R. Soleti, L. Moreno, A. Cogolludo, R. Andriantsitohaina, C. Martinez, F. Perez-Vizcaino (Madrid, Spain; Angers, France)
| |
Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension
S. J. Dumas, F. Perros, G. Bru-Mercier, B. Ranchoux, C. Rücker-Martin, E. Gouadon, M. Vocelle, P. Dorfmüller, E. Fadel, M. Humbert, S. Cohen-Kaminsky (Le Kremlin-Bicêtre, Châtenay-Malabry, Le Plessis-Robinson, France)
| |
Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
L. Dewachter, C. Dewachter, A. Belhaj, S. Lalande, B. Rondelet, M. Remmelink, J. L. Vachiéry, R. Naeije (Brussels, Dinant, Belgium)
| |
Nebivolol and pulmonary hypertension
F. Perros, S. Bentebbal, B. Ranchoux, P. Dorfmüller, F. Lecerf, E. Fadel, G. Simonneau, M. Humbert, H. J. Bogaard, S. Eddahibi (Le Kremlin-Bicetre, Le Plessis-Robinson, France; Amsterdam, Netherlands)
| |